News

Accoding to Affymax, the decrease in revenue was the result of decreased collaboration revenue, driven primarily by lower reimbursement of clinical trial expenses, from its collaboration with Takeda

EnVivo claimed that, by acting as a co-agonist and sensitising the alpha-7 receptor, EVP-6124 makes it possible for smaller amounts of naturally occurring ACh, typically found in individuals

The certification covers single-dose and multiple-dose toxicology studies in both rodents and non-rodents, GeneTox studies (Ames, micronucleus, and chromosome aberration), and toxicokinetic studies. According to WuXi PharmaTech, the

Halozyme has posted a net loss of $12.4m for the third quarter 2010, or $0.13 loss per diluted share, compared to net loss of $13.91m, or $0.16 loss

The study reported on the use of non-invasive technologies for quantitative sweat function, and correlated these results with the nature and location of ectodysplasin A (EDA) gene defects

The grants are being provided under section 48D of the Internal Revenue Code, enacted as part of the Patient Protection and Affordable Care Act of 2010. NP001 is

According to Eisai, Crystal Veil can be used as a preventative measure against airborne allergens such as pollen and house dust by applying a single drop the size

Nutra Pharma is expected to use the grant proceeds to support additional clinical work on its pain treatments. Nutra Pharma chairman and CEO Rik Deitsch said that it

Aceto has posted a net income of $2.8m for the first quarter 2010, or $0.11 per diluted share, compared to $1m, or $0.04 per diluted share, for the